NXTC

$0.00

(

+0.00%

) Quote details
Add to Watchlist Run Backtest
stock

NextCure  Inc

NASDAQ | NXTC

8.69

USD

+$0.00

(

+0.00%

)

At Close (As of Oct 16, 2025)

$23.28M

Market Cap

-

P/E Ratio

-25.97

EPS

$19.20

52 Week High

$2.68

52 Week Low

HEALTHCARE

Sector

NXTC Chart

Recent Chart
Price Action

NXTC Technicals

Tags:

NXTC Earnings

Yearly Income Statement (As of Dec 31, 2024)

Field Value (USD)
Gross Profit -$2.9M
Total Revenue $0
Cost Of Revenue $2.9M
Costof Goods And Services Sold $2.9M
Operating Income -$60M
Selling General And Administrative $16M
Research And Development $41M
Operating Expenses $60M
Investment Income Net -
Net Interest Income -
Interest Income -
Interest Expense -
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $2.9M
Income Before Tax -$56M
Income Tax Expense -
Interest And Debt Expense -
Net Income From Continuing Operations -$56M
Comprehensive Income Net Of Tax -
Ebit -$57M
Ebitda -$54M
Net Income -$56M

Revenue & Profitability

Earnings Performance

NXTC Financials

yearly Balance Sheet (As of Dec 31, 2024)

Field Value (USD)
Total Assets $81M
Total Current Assets $72M
Cash And Cash Equivalents At Carrying Value $28M
Cash And Short Term Investments $28M
Inventory -
Current Net Receivables $300K
Total Non Current Assets $9.1M
Property Plant Equipment -
Accumulated Depreciation Amortization Ppe -
Intangible Assets -
Intangible Assets Excluding Goodwill -
Goodwill -
Investments -
Long Term Investments -
Short Term Investments $41M
Other Current Assets $2.9M
Other Non Current Assets -
Total Liabilities $15M
Total Current Liabilities $9.6M
Current Accounts Payable $5.4M
Deferred Revenue -
Current Debt -
Short Term Debt $796K
Total Non Current Liabilities $5.8M
Capital Lease Obligations $5.9M
Long Term Debt -
Current Long Term Debt -
Long Term Debt Noncurrent -
Short Long Term Debt Total $5.9M
Other Current Liabilities $3.4M
Other Non Current Liabilities $661K
Total Shareholder Equity $65M
Treasury Stock -
Retained Earnings -$380M
Common Stock $28K
Common Stock Shares Outstanding $2.3M

yearly Cash Flow (As of Dec 31, 2024)

Field Value (USD)
Operating Cashflow -$41M
Payments For Operating Activities -
Proceeds From Operating Activities -
Change In Operating Liabilities -
Change In Operating Assets -
Depreciation Depletion And Amortization $2.9M
Capital Expenditures $474K
Change In Receivables -
Change In Inventory -
Profit Loss -
Cashflow From Investment $55M
Cashflow From Financing $144K
Proceeds From Repayments Of Short Term Debt -
Payments For Repurchase Of Common Stock -
Payments For Repurchase Of Equity -
Payments For Repurchase Of Preferred Stock -
Dividend Payout -
Dividend Payout Common Stock -
Dividend Payout Preferred Stock -
Proceeds From Issuance Of Common Stock -
Proceeds From Issuance Of Long Term Debt And Capital Securities Net -
Proceeds From Issuance Of Preferred Stock -
Proceeds From Repurchase Of Equity -
Proceeds From Sale Of Treasury Stock -
Change In Cash And Cash Equivalents -
Change In Exchange Rate -
Net Income -$56M

yearly Income Statement (As of Dec 31, 2024)

Field Value (USD)
Gross Profit -$2.9M
Total Revenue $0
Cost Of Revenue $2.9M
Costof Goods And Services Sold $2.9M
Operating Income -$60M
Selling General And Administrative $16M
Research And Development $41M
Operating Expenses $60M
Investment Income Net -
Net Interest Income -
Interest Income -
Interest Expense -
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $2.9M
Income Before Tax -$56M
Income Tax Expense -
Interest And Debt Expense -
Net Income From Continuing Operations -$56M
Comprehensive Income Net Of Tax -
Ebit -$57M
Ebitda -$54M
Net Income -$56M

NXTC News

NXTC Profile

NextCure  Inc Profile

Sector: HEALTHCARE

Industry: BIOTECHNOLOGY

NextCure, Inc. (NXTC) is a clinical-stage biopharmaceutical firm located in Beltsville, Maryland, dedicated to pioneering immunomedicines for cancer and various immune-related disorders. Utilizing its advanced NEX-T technology platform, the company aims to restore and optimize immune function, thereby developing innovative treatment options for patients with significant therapeutic gaps. With a robust pipeline and a commitment to addressing pressing healthcare challenges, NextCure is strategically positioned to play a vital role in the burgeoning immunotherapy landscape.

VHAI
0.00%
$0.00
RANI
+248.26%
$1.64
BYND
+24.15%
$0.64
YYAI
+0.83%
$0.12
YDKG
-40.50%
$0.05
NAYA
+85.67%
$1.40
CGBS
-39.47%
$0.03
BITF
-5.20%
$5.00
NVDA
+0.77%
$183.22
INTC
+0.46%
$37.01
F
+1.57%
$11.92
GDXD
+20.55%
$0.72
RGTI
-2.92%
$46.56
PLUG
-2.29%
$3.40
ARTV
+116.96%
$6.01
BURU
-0.26%
$0.33
AADI
+24.28%
$2.61
TSLA
+2.46%
$439.31
DNN
-5.33%
$2.92
KVUE
-13.22%
$14.11
TLRY
-8.33%
$1.54
BBD
+1.07%
$3.29
HPE
-10.14%
$22.50
IONZ
+8.16%
$3.72
NVTS
-6.20%
$14.66
CAN
-4.19%
$1.60
HIMS
-15.75%
$49.83
NIO
-1.70%
$6.71
RXRX
-7.86%
$5.86
AXDX
-61.36%
$0.03
BTG
-6.31%
$5.56
ELBM
+35.36%
$2.22
ETHD
+2.12%
$4.08
LAES
+6.60%
$6.78
T
+0.53%
$26.34
BLMZ
-3.85%
$0.18
WTO
-47.99%
$0.07
CIFR
+0.21%
$18.76
ACHR
-6.08%
$11.14
GNPX
-23.17%
$0.36
RGTZ
+29.08%
$11.23
AMD
-0.30%
$233.84
MARA
-3.42%
$19.57
AAPL
+1.95%
$252.29
SOFI
-0.22%
$26.54
JOBY
-2.48%
$15.67
BAC
+1.71%
$51.30
IREN
-9.04%
$61.83
AMZN
-0.66%
$213.04
RIG
+0.61%
$3.25
QBTS
-5.85%
$38.08
PLTR
+0.01%
$178.15
RF
+0.79%
$23.53
EPWK
-18.35%
$0.07
SOUN
-9.03%
$18.88
PFE
+1.19%
$24.52
GRAB
-3.54%
$5.71
RMBL
+60.50%
$3.21
ABEV
+1.12%
$2.25
ADAP
+2.51%
$0.20
ADD
-25.47%
$0.05
ASST
-7.28%
$0.83
BMNR
-2.21%
$49.95
QUBT
-1.22%
$18.51
ORCL
-6.88%
$291.45
CRML
+7.41%
$20.86
ONDS
-6.22%
$7.68
DFLI
+2.25%
$1.36
SRM
+53.27%
$10.30
SLB
-1.01%
$32.58
SNAP
-1.24%
$7.66
LNKS
+30.35%
$0.73
IONQ
-3.97%
$62.98
GPUS
-12.54%
$0.31
HBAN
+1.13%
$15.54
WULF
+0.50%
$13.93
BTBT
-0.89%
$3.65
NOK
+1.14%
$5.74
RR
-4.05%
$5.44
ATAI
+17.70%
$6.45
SMR
-7.09%
$44.26
APLD
-6.55%
$34.24
CLSK
-2.32%
$19.52
CUTR
-10.19%
$0.09
PET
-59.91%
$0.04
GWH
+16.04%
$5.28
GOOGL
+0.73%
$253.30
AAL
+0.21%
$11.91
QS
-0.64%
$15.36
VALE
-0.04%
$11.10
NAK
-8.92%
$2.04
UUUU
-3.08%
$21.01
WLGS
-5.57%
$0.04
FNB
+2.93%
$15.08
RIVN
-3.72%
$12.91
CRWV
-3.43%
$136.87
AG
-8.51%
$14.02
WOK
-31.91%
$0.03
ETWO
0.00%
$3.30
FEMY
-0.93%
$0.73
VHAI
0.00%
$0.00
RANI
+248.26%
$1.64
BYND
+24.15%
$0.64
YYAI
+0.83%
$0.12
YDKG
-40.50%
$0.05
NAYA
+85.67%
$1.40
CGBS
-39.47%
$0.03
BITF
-5.20%
$5.00
NVDA
+0.77%
$183.22
INTC
+0.46%
$37.01
F
+1.57%
$11.92
GDXD
+20.55%
$0.72
RGTI
-2.92%
$46.56
PLUG
-2.29%
$3.40
ARTV
+116.96%
$6.01
BURU
-0.26%
$0.33
AADI
+24.28%
$2.61
TSLA
+2.46%
$439.31
DNN
-5.33%
$2.92
KVUE
-13.22%
$14.11
TLRY
-8.33%
$1.54
BBD
+1.07%
$3.29
HPE
-10.14%
$22.50
IONZ
+8.16%
$3.72
NVTS
-6.20%
$14.66
CAN
-4.19%
$1.60
HIMS
-15.75%
$49.83
NIO
-1.70%
$6.71
RXRX
-7.86%
$5.86
AXDX
-61.36%
$0.03
BTG
-6.31%
$5.56
ELBM
+35.36%
$2.22
ETHD
+2.12%
$4.08
LAES
+6.60%
$6.78
T
+0.53%
$26.34
BLMZ
-3.85%
$0.18
WTO
-47.99%
$0.07
CIFR
+0.21%
$18.76
ACHR
-6.08%
$11.14
GNPX
-23.17%
$0.36
RGTZ
+29.08%
$11.23
AMD
-0.30%
$233.84
MARA
-3.42%
$19.57
AAPL
+1.95%
$252.29
SOFI
-0.22%
$26.54
JOBY
-2.48%
$15.67
BAC
+1.71%
$51.30
IREN
-9.04%
$61.83
AMZN
-0.66%
$213.04
RIG
+0.61%
$3.25
QBTS
-5.85%
$38.08
PLTR
+0.01%
$178.15
RF
+0.79%
$23.53
EPWK
-18.35%
$0.07
SOUN
-9.03%
$18.88
PFE
+1.19%
$24.52
GRAB
-3.54%
$5.71
RMBL
+60.50%
$3.21
ABEV
+1.12%
$2.25
ADAP
+2.51%
$0.20
ADD
-25.47%
$0.05
ASST
-7.28%
$0.83
BMNR
-2.21%
$49.95
QUBT
-1.22%
$18.51
ORCL
-6.88%
$291.45
CRML
+7.41%
$20.86
ONDS
-6.22%
$7.68
DFLI
+2.25%
$1.36
SRM
+53.27%
$10.30
SLB
-1.01%
$32.58
SNAP
-1.24%
$7.66
LNKS
+30.35%
$0.73
IONQ
-3.97%
$62.98
GPUS
-12.54%
$0.31
HBAN
+1.13%
$15.54
WULF
+0.50%
$13.93
BTBT
-0.89%
$3.65
NOK
+1.14%
$5.74
RR
-4.05%
$5.44
ATAI
+17.70%
$6.45
SMR
-7.09%
$44.26
APLD
-6.55%
$34.24
CLSK
-2.32%
$19.52
CUTR
-10.19%
$0.09
PET
-59.91%
$0.04
GWH
+16.04%
$5.28
GOOGL
+0.73%
$253.30
AAL
+0.21%
$11.91
QS
-0.64%
$15.36
VALE
-0.04%
$11.10
NAK
-8.92%
$2.04
UUUU
-3.08%
$21.01
WLGS
-5.57%
$0.04
FNB
+2.93%
$15.08
RIVN
-3.72%
$12.91
CRWV
-3.43%
$136.87
AG
-8.51%
$14.02
WOK
-31.91%
$0.03
ETWO
0.00%
$3.30
FEMY
-0.93%
$0.73
2025 © AfterPullback LTD

Charts powered by TradingView

Market data may be delayed by 15 minutes or more and is provided by financial exchanges or third-party providers. AfterPullback does not verify or guarantee its accuracy and assumes no responsibility to do so. This website is not operated by a licensed attorney, accountant, or financial advisor. Nothing on this site constitutes financial advice or replaces consultation with a qualified professional who understands your specific circumstances. Always consult a licensed financial advisor before making investment decisions.